Literature DB >> 24666716

Lifetime experiences of hypomanic symptoms are associated with delayed and irregular sleep-wake cycle and seasonality in non-clinical adult samples.

Moonoh Bae1, Kounseok Lee1, Ji Hyun Baek1, Ji Sun Kim2, Youngah Cho1, Seunghyong Ryu1, Kyooseob Ha3, Kyung Sue Hong4.   

Abstract

OBJECTIVES: Disturbances of the sleep-wake cycle and seasonality have been reported in patients with bipolar disorder (BD). Considering that BD seems to be a spectrum condition in terms of clinical and biological characteristics, circadian and seasonal rhythm related to BD could be detected in non-clinical individuals with subthreshold bipolarity. The aim of this study was to screen past hypomanic symptoms in non-clinical samples and investigate their association with deviated sleep-wake cycle and seasonality.
METHODS: Lifetime history of hypomanic symptoms was assessed with the Hypomania Checklist-32 (HCL-32). Circadian preference, variability of sleep-wake time and seasonal changes in mood and behavior were evaluated on a lifetime-basis in non-clinical adult samples (n=313), using the Composite Scale of Morningness (CSM), the Sleep Timing Questionnaire (STQ), and the Seasonal Pattern Assessment Questionnaire (SPAQ).
RESULTS: Two subdomains of hypomanic symptoms were identified through factor analysis of HCL-32, i.e., "active/elated" factor and "irritable/risk-taking" factor. The HCL-32 total score (p<0.001) and the "active/elated" factor score (p=0.028) were weakly correlated only with seasonality, whereas the "irritable/risk-taking" factor score was associated not only with seasonality (p<0.001), but also with evening preference (p<0.001) and irregularity of sleep-wake times (p=0.001~0.011).
CONCLUSION: Circadian and seasonal characteristics related to BD are also associated with a past history of hypomanic symptoms in non-clinical samples, especially "irritable/risk-taking" symptoms, suggesting the existence of subclinical presentation of BD and their biological traits.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24666716     DOI: 10.1016/j.comppsych.2014.02.012

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  5 in total

1.  Factorial structure and familial aggregation of the Hypomania Checklist-32 (HCL-32): Results of the NIMH Family Study of Affective Spectrum Disorders.

Authors:  Jennifer Glaus; Anna Van Meter; Lihong Cui; Ciro Marangoni; Kathleen R Merikangas
Journal:  Compr Psychiatry       Date:  2018-04-03       Impact factor: 3.735

2.  "Always Look on the Bright Side of Life!" - Higher Hypomania Scores Are Associated with Higher Mental Toughness, Increased Physical Activity, and Lower Symptoms of Depression and Lower Sleep Complaints.

Authors:  Leila Jahangard; Anahita Rahmani; Mohammad Haghighi; Mohammad Ahmadpanah; Dena Sadeghi Bahmani; Ali R Soltanian; Shahriar Shirzadi; Hafez Bajoghli; Markus Gerber; Edith Holsboer-Trachsler; Serge Brand
Journal:  Front Psychol       Date:  2017-12-12

Review 3.  Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology.

Authors:  Michael J McCarthy; John F Gottlieb; Robert Gonzalez; Colleen A McClung; Lauren B Alloy; Sean Cain; Davide Dulcis; Bruno Etain; Benicio N Frey; Corrado Garbazza; Kyle D Ketchesin; Dominic Landgraf; Heon-Jeong Lee; Cynthia Marie-Claire; Robin Nusslock; Alessandra Porcu; Richard Porter; Philipp Ritter; Jan Scott; Daniel Smith; Holly A Swartz; Greg Murray
Journal:  Bipolar Disord       Date:  2021-12-10       Impact factor: 5.345

Review 4.  Integrated neurobiology of bipolar disorder.

Authors:  Vladimir Maletic; Charles Raison
Journal:  Front Psychiatry       Date:  2014-08-25       Impact factor: 4.157

5.  Investigation of the clinical utility of the hypomania checklist 32 (HCL-32) for the screening of bipolar disorders in the non-clinical adult population.

Authors:  Kounseok Lee; Hyeji Oh; Eun-Ho Lee; Joo Hyun Kim; Ji-Hae Kim; Kyung Sue Hong
Journal:  BMC Psychiatry       Date:  2016-05-04       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.